Accordingly, they see a market driver in terms of monitoring gut health to provide general analytics as well as to identify triggers for the need to apply mediation measures such as the consumption of prebiotics and probiotics to ensure proper gut health. This is especially a concern with particularly sensitive individuals.
This is because the gut biome may be impacted by disinfectants due to the die-off of beneficial bacteria in the digestive system of humans. They see the need to monitor otherwise healthy people on an ongoing basis due to the substantial amount of disinfectant in the ambient environment. Since the analyst initiated coverage of this market four years ago, they have identified an additional substantial market driver for smart pills in the wake of the COVID-19 pandemic. This has substantial implications for various remote healthcare applications including endoscopy, gastrointestinal monitoring in general, as well as other investigative procedures that would otherwise be more invasive, expensive, and time-consuming for the patient.Ĭoupled with next-generation data analytics, healthcare practitioners may leverage these MedTech solutions to provide diagnostics to virtually anyone, anywhere on a substantially lower cost basis. Smart pills represent a significant area for next-generation MedTech diagnostic solutions in which ingestible tablets or capsules embedded with sensor, camera, tracker, or microchip are swallowed by a person for purposes of obtaining physiological status and activities.Ĭombined with IoT, smart pills allow for data capture and monitoring of the subject, regardless of their location. Medical Technology (MedTech) is poised to benefit greatly from the convergence of Internet of Things (IoT) technologies including machine-to-machine communications, smart micro or nano-sensors, and other IoT components.
0 kommentar(er)
